Hide metadata

dc.date.accessioned2021-04-24T19:44:39Z
dc.date.available2021-04-24T19:44:39Z
dc.date.created2020-09-23T15:30:40Z
dc.date.issued2020
dc.identifier.citationBurton, Joshua Umu, Sinan Uğur Langseth, Hilde Grotmol, Tom Grimsrud, Tom Kristian Haugen, Trine B. Rounge, Trine Ballestad . Serum RNA profiling in the 10-year period prior to diagnosis of testicular germ cell tumour. Frontiers in Oncology. 2020, 10, 1-13
dc.identifier.urihttp://hdl.handle.net/10852/85567
dc.description.abstractAlthough testicular germ cell tumor (TGCT) overall is highly curable, patients may experience late effects after treatment. An increased understanding of the mechanisms behind the development of TGCT may pave the way for better outcome for patients. To elucidate molecular changes prior to TGCT diagnosis we sequenced small RNAs in serum from 69 patients who were later diagnosed with TGCT and 111 matched controls. The deep RNA profiles, with on average 18 million sequences per sample, comprised of nine classes of RNA, including microRNA. We found that circulating RNA signals differed significantly between cases and controls regardless of time to diagnosis. Different levels of TSIX related to X-chromosome inactivation and TEX101 involved in spermatozoa production are among the interesting findings. The RNA signals differed between seminoma and non-seminoma TGCT subtypes, with seminoma cases showing lower levels of RNAs and non-seminoma cases showing higher levels of RNAs, compared with controls. The differentially expressed RNAs were typically associated with cancer related pathways. Our results indicate that circulating RNA profiles change during TGCT development according to histology and may be useful for early detection of this tumor type.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleSerum RNA profiling in the 10-year period prior to diagnosis of testicular germ cell tumour
dc.typeJournal article
dc.creator.authorBurton, Joshua
dc.creator.authorUmu, Sinan Uğur
dc.creator.authorLangseth, Hilde
dc.creator.authorGrotmol, Tom
dc.creator.authorGrimsrud, Tom Kristian
dc.creator.authorHaugen, Trine B.
dc.creator.authorRounge, Trine Ballestad
cristin.unitcode185,15,5,0
cristin.unitnameInstitutt for informatikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1832663
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in Oncology&rft.volume=10&rft.spage=1&rft.date=2020
dc.identifier.jtitleFrontiers in Oncology
dc.identifier.volume10
dc.identifier.doihttps://doi.org/10.3389/fonc.2020.574977
dc.identifier.urnURN:NBN:no-88242
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2234-943X
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/85567/2/fonc-10-574977.pdf
dc.type.versionPublishedVersion
cristin.articleid574977


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International